These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1213 related items for PubMed ID: 26169124
21. Research on the efficacy of Celastrus Orbiculatus in suppressing TGF-β1-induced epithelial-mesenchymal transition by inhibiting HSP27 and TNF-α-induced NF-κ B/Snail signaling pathway in human gastric adenocarcinoma. Zhu Y, Liu Y, Qian Y, Dai X, Yang L, Chen J, Guo S, Hisamitsu T. BMC Complement Altern Med; 2014 Nov 05; 14():433. PubMed ID: 25370696 [Abstract] [Full Text] [Related]
22. Glaucocalyxin A reverses EMT and TGF-β1-induced EMT by inhibiting TGF-β1/Smad2/3 signaling pathway in osteosarcoma. Jiang X, Zhang Z, Song C, Deng H, Yang R, Zhou L, Sun Y, Zhang Q. Chem Biol Interact; 2019 Jul 01; 307():158-166. PubMed ID: 31059706 [Abstract] [Full Text] [Related]
23. Structure Identification of ViceninII Extracted from Dendrobium officinale and the Reversal of TGF-β1-Induced Epithelial⁻Mesenchymal Transition in Lung Adenocarcinoma Cells through TGF-β/Smad and PI3K/Akt/mTOR Signaling Pathways. Luo Y, Ren Z, Du B, Xing S, Huang S, Li Y, Lei Z, Li D, Chen H, Huang Y, Wei G. Molecules; 2019 Jan 02; 24(1):. PubMed ID: 30609689 [Abstract] [Full Text] [Related]
24. Halofuginone inhibits radiotherapy-induced epithelial-mesenchymal transition in lung cancer. Chen Y, Liu W, Wang P, Hou H, Liu N, Gong L, Wang Y, Ji K, Zhao L, Wang P. Oncotarget; 2016 Nov 01; 7(44):71341-71352. PubMed ID: 27533085 [Abstract] [Full Text] [Related]
25. Toosendanin, a natural product, inhibited TGF-β1-induced epithelial-mesenchymal transition through ERK/Snail pathway. Luo W, Liu X, Sun W, Lu JJ, Wang Y, Chen X. Phytother Res; 2018 Oct 01; 32(10):2009-2020. PubMed ID: 29952428 [Abstract] [Full Text] [Related]
26. Oridonin prevents epithelial-mesenchymal transition and TGF-β1-induced epithelial-mesenchymal transition by inhibiting TGF-β1/Smad2/3 in osteosarcoma. Sun Y, Jiang X, Lu Y, Zhu J, Yu L, Ma B, Zhang Q. Chem Biol Interact; 2018 Dec 25; 296():57-64. PubMed ID: 30243739 [Abstract] [Full Text] [Related]
27. Resolvin D1 inhibits TGF-β1-induced epithelial mesenchymal transition of A549 lung cancer cells via lipoxin A4 receptor/formyl peptide receptor 2 and GPR32. Lee HJ, Park MK, Lee EJ, Lee CH. Int J Biochem Cell Biol; 2013 Dec 25; 45(12):2801-7. PubMed ID: 24120851 [Abstract] [Full Text] [Related]
28. Interaction of hnRNP K with MAP 1B-LC1 promotes TGF-β1-mediated epithelial to mesenchymal transition in lung cancer cells. Li L, Yan S, Zhang H, Zhang M, Huang G, Chen M. BMC Cancer; 2019 Sep 06; 19(1):894. PubMed ID: 31492158 [Abstract] [Full Text] [Related]
29. HPIP silencing inhibits TGF-β1-induced EMT in lung cancer cells. Shi S, Zhao J, Wang J, Mi D, Ma Z. Int J Mol Med; 2017 Feb 06; 39(2):479-483. PubMed ID: 28075456 [Abstract] [Full Text] [Related]
30. Paeoniflorin suppresses TGF-β mediated epithelial-mesenchymal transition in pulmonary fibrosis through a Smad-dependent pathway. Ji Y, Dou YN, Zhao QW, Zhang JZ, Yang Y, Wang T, Xia YF, Dai Y, Wei ZF. Acta Pharmacol Sin; 2016 Jun 06; 37(6):794-804. PubMed ID: 27133302 [Abstract] [Full Text] [Related]
31. Luteolin attenuates TGF-β1-induced epithelial-mesenchymal transition of lung cancer cells by interfering in the PI3K/Akt-NF-κB-Snail pathway. Chen KC, Chen CY, Lin CR, Yang TY, Chen TH, Wu LC, Wu CC. Life Sci; 2013 Dec 05; 93(24):924-33. PubMed ID: 24140887 [Abstract] [Full Text] [Related]
32. Knockdown of Linc00511 inhibits TGF-β-induced cell migration and invasion by suppressing epithelial-mesenchymal transition and down-regulating MMPs expression. Jiang L, Xie X, Bi R, Ding F, Mei J. Biomed Pharmacother; 2020 May 05; 125():109049. PubMed ID: 32092827 [Abstract] [Full Text] [Related]
33. Osthole inhibited TGF β-induced epithelial-mesenchymal transition (EMT) by suppressing NF-κB mediated Snail activation in lung cancer A549 cells. Feng H, Lu JJ, Wang Y, Pei L, Chen X. Cell Adh Migr; 2017 Sep 03; 11(5-6):464-475. PubMed ID: 28146373 [Abstract] [Full Text] [Related]
34. Transglutaminase-2 induces N-cadherin expression in TGF-β1-induced epithelial mesenchymal transition via c-Jun-N-terminal kinase activation by protein phosphatase 2A down-regulation. Park MK, You HJ, Lee HJ, Kang JH, Oh SH, Kim SY, Lee CH. Eur J Cancer; 2013 May 03; 49(7):1692-705. PubMed ID: 23290789 [Abstract] [Full Text] [Related]
35. Human peroxiredoxin 1 modulates TGF-β1-induced epithelial-mesenchymal transition through its peroxidase activity. Ha B, Kim EK, Kim JH, Lee HN, Lee KO, Lee SY, Jang HH. Biochem Biophys Res Commun; 2012 Apr 27; 421(1):33-7. PubMed ID: 22475482 [Abstract] [Full Text] [Related]
36. Norepinephrine induced epithelial-mesenchymal transition in HT-29 and A549 cells in vitro. Zhang J, Deng YT, Liu J, Wang YQ, Yi TW, Huang BY, He SS, Zheng B, Jiang Y. J Cancer Res Clin Oncol; 2016 Feb 27; 142(2):423-35. PubMed ID: 26358081 [Abstract] [Full Text] [Related]
37. BIX02189 inhibits TGF-β1-induced lung cancer cell metastasis by directly targeting TGF-β type I receptor. Park SJ, Choi YS, Lee S, Lee YJ, Hong S, Han S, Kim BC. Cancer Lett; 2016 Oct 28; 381(2):314-22. PubMed ID: 27543359 [Abstract] [Full Text] [Related]
38. FBI-1 inhibits epithelial-to-mesenchymal transition, migration, and invasion in lung adenocarcinoma A549 cells by downregulating transforming growth factor-β1 signaling pathway. Lim W, Jeon BN, Kim YJ, Kim KH, Ko H. J Cell Biochem; 2022 Mar 28; 123(3):644-656. PubMed ID: 34989006 [Abstract] [Full Text] [Related]
39. Geraniin inhibits migration and invasion of human osteosarcoma cancer cells through regulation of PI3K/Akt and ERK1/2 signaling pathways. Wang Y, Wan D, Zhou R, Zhong W, Lu S, Chai Y. Anticancer Drugs; 2017 Oct 28; 28(9):959-966. PubMed ID: 28704237 [Abstract] [Full Text] [Related]
40. MiR-134/487b/655 cluster regulates TGF-β-induced epithelial-mesenchymal transition and drug resistance to gefitinib by targeting MAGI2 in lung adenocarcinoma cells. Kitamura K, Seike M, Okano T, Matsuda K, Miyanaga A, Mizutani H, Noro R, Minegishi Y, Kubota K, Gemma A. Mol Cancer Ther; 2014 Feb 28; 13(2):444-53. PubMed ID: 24258346 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]